EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Feasibility, Acceptability, and Preliminary Efficacy of Acceptance Commitment Therapy for Adults Living With Inflammatory Bowel Disease and Distress

Daniel Romano iD, Susan Chesterman, Matthew Fuller-Tyszkiewicz, Subhadra Evans, Madeleine Dober, Richard Gearry, Peter R Gibson, Simon Knowles, Andrew McCombie, Eric O, Lisa Olive, Leanne Raven und 2 weitere

Inflammatory Bowel Diseases · 2024

DOI: 10.1093/ibd/izad122 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Inflammatory Bowel Diseases, 2024. Verfasst von Daniel Romano und 13 weiteren Autor:innen. Beteiligte Einrichtung: School of Psychology, Deakin University, Geelong, Victoria, Australia. Hauptthemen laut MEDLINE: Acceptance and Commitment Therapy, Feasibility Studies, Quality of Life, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Litwin IBD Pioneers, Crohn's and Colitis Foundation of America.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The bidirectional relationship between inflammatory bowel disease (IBD) flare-ups and depression/anxiety symptoms has prompted investigations into psychotherapy to improve health-related quality of life (HRQoL) by targeting depression and anxiety. Acceptance commitment therapy (ACT) is effective in improving symptoms of depression and anxiety in people with chronic diseases, yet minimal research has examined ACT’s effectiveness for IBD. This study examines the feasibility, acceptability, and preliminary efficacy of the ACTforIBD program, an online program codesigned with consumers to deliver ACT to those with IBD.

Methods

Adults with IBD and symptoms of mild-moderate distress were randomized to ACTforIBD or an active control (psychoeducation) condition. Participants completed 8 weekly, 1-hour sessions, 4 of which were therapist facilitated. Feasibility was based on recruitment and retention and acceptability was derived from postprogram satisfaction measures. Preliminary efficacy was determined by group differences in rate of change in study outcomes from baseline to postprogram.

Results

Of 62 participants (89% women, 11% men; mean age 33 years), 55 completed the program (ACTforIBD: n = 26 [83.9%]; active control: n = 29 [93.5%]). Adherence and acceptability were high in the ACTforIBD group, with 80% of participants completing all self-directed modules and 78% of participants expressing satisfaction with the program. Significant and marginally significant group × time interactions were found for anxiety symptoms (b = -1.89; 95% confidence interval, -3.38 to -0.42) and psychological HRQoL (b = -0.04; 95% confidence interval, -0.07 to 0.01), showing decreased anxiety and increased psychological HRQoL in the intervention group.

Conclusions

ACTforIBD is feasible, acceptable, and improved anxiety symptoms, and psychological HRQoL. This highlights the need for a full-scale randomized controlled trial to further examine the program’s efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acceptance and Commitment TherapyFeasibility StudiesQuality of LifeInflammatory Bowel DiseasesAnxietyDepressionHumansFemaleMaleAdultTreatment OutcomeMiddle AgedPatient Acceptance of Health CarePsychological Distress

Stichwörter der Autor:innen

acceptance commitment therapydistressfeasibilitypreliminary efficacyrandomized controlled trial

Autor:innen und Institutionen

  • School of Psychology, Deakin University, Geelong, Victoria, Australia.
  • Department of Medicine, Christchurch School of Medicine and Health Sciences, Univeresity of Otago, Christchurch, New Zealand.
  • Department of Gastroenterology, Alfred Health, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
  • School of Health Sciences, Swinburne University of Technology, Hawthorn, Victoria, Australia.
  • Department of General Surgery, Te Whatu Ora Ōtautahi (Health New Zealand Christchurch), Christchurch, New Zealand.
  • Faculty of Health, Deakin University, Burwood, Victoria, Australia.

ORCID-Profile: Daniel Romano, Leesa Van Niekerk, Antonina Mikocka-Walus

Förderung

  • Litwin IBD Pioneers
  • Crohn's and Colitis Foundation of America

Zitieren

APA

Romano, D., Chesterman, S., Fuller-Tyszkiewicz, M., Evans, S., Dober, M., Gearry, R., Gibson, P. R., Knowles, S., McCombie, A., O, E., Olive, L., Raven, L., Van Niekerk, L., & Mikocka-Walus, A. (2024). Feasibility, Acceptability, and Preliminary Efficacy of Acceptance Commitment Therapy for Adults Living With Inflammatory Bowel Disease and Distress. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izad122

Vancouver

Romano D, Chesterman S, Fuller-Tyszkiewicz M, Evans S, Dober M, Gearry R, et al. Feasibility, Acceptability, and Preliminary Efficacy of Acceptance Commitment Therapy for Adults Living With Inflammatory Bowel Disease and Distress. Inflammatory Bowel Diseases. 2024. doi:10.1093/ibd/izad122

BibTeX
@article{Romano2024,
  author = {Romano, Daniel and Chesterman, Susan and Fuller-Tyszkiewicz, Matthew and Evans, Subhadra and Dober, Madeleine and Gearry, Richard and Gibson, Peter R and Knowles, Simon and McCombie, Andrew and O, Eric and Olive, Lisa and Raven, Leanne and Van Niekerk, Leesa and Mikocka-Walus, Antonina},
  title = {Feasibility, Acceptability, and Preliminary Efficacy of Acceptance Commitment Therapy for Adults Living With Inflammatory Bowel Disease and Distress},
  journal = {Inflammatory Bowel Diseases},
  year = {2024},
  doi = {10.1093/ibd/izad122}
}
Kostenlos starten →